Stock Events

Stock Events

NetraMark 

$0.4435
16
-$0.04-7.85%Wednesday 16:13

Statistics

Day High
0.5055
Day Low
0.5055
52W High
0.97
52W Low
0.3985
Volume
500
Avg. Volume
1,664
Mkt Cap
41.97M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-1,234.38%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
301,263Revenue
-3.72MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AINMF. It's not an investment recommendation.
Amazon
2
AMZN
Alphabet
2
GOOG
Ethereum
2
ETH.CRYPTO
YieldMax MSTR Option Income Strategy
2
MSTY

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a major player in the pharmaceutical industry, directly competing with NetraMark in drug development and personalized medicine.
Novartis
NVS
Mkt Cap268B
Novartis is involved in advanced pharmaceuticals and personalized healthcare solutions, overlapping with NetraMark's focus areas.
Merck
MRK
Mkt Cap356.01B
Merck operates in the pharmaceutical sector, focusing on innovative therapies that compete with NetraMark's offerings.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly is a leader in pharmaceuticals, particularly in areas that utilize AI for drug discovery, similar to NetraMark's approach.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline focuses on research in pharmaceuticals, competing with NetraMark in the development of new drugs and health solutions.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie works in biopharmaceuticals, directly competing with NetraMark in therapeutic areas and personalized medicine.
AMGEN
AMGN
Mkt Cap217.9B
Amgen specializes in biotechnological medicines, which aligns with NetraMark's focus on innovative healthcare solutions.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol-Myers Squibb is a major biopharma company, competing in the same space as NetraMark with a focus on serious diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap75.69B
Regeneron Pharmaceuticals focuses on genetic and biomarker-driven drug development, similar to NetraMark's AI-driven approach.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.93B
Vertex Pharmaceuticals is known for its scientific innovations in healthcare, competing with NetraMark in drug discovery and development.

About

NetraMark Holdings, Inc. engages in the development of artificial intelligence and machine learning solutions. The company was founded by Dr. Joseph Geraci on May 8, 2019 and is headquartered in Toronto, Canada.
Show More
CEO
Mr. George Achilleos
Country
Canada
ISIN
CA64119M1059
WKN
000A3D5X9

Listings

STU
DE
PF0.STU
MU
DE
PF0.MU
CN
CA
MEND.CN
OTC Link
US
AINMF

0 Comments

Share your thoughts

FAQs

What is NetraMark stock price today?▼
The current price of AINMF is $0.44 USD — it has decreased by -7.85% in the past 24 hours. Watch NetraMark stock price performance more closely on the chart.
What is NetraMark stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange NetraMark stocks are traded under the ticker AINMF.
Is NetraMark stock price growing?▼
AINMF stock has fallen by -0.61% compared to the previous week, the month change is a -9.09% fall, over the last year NetraMark has showed a -47.95% decrease.
What is NetraMark market cap?▼
Today NetraMark has the market capitalization of 41.97M
What is NetraMark revenue for the last year?▼
NetraMark revenue for the last year amounts to 301,263 USD.
What is NetraMark net income for the last year?▼
AINMF net income for the last year is -3.72M USD.
In which sector is NetraMark located?▼
NetraMark operates in the Health & Wellness sector.
When did NetraMark complete a stock split?▼
NetraMark has not had any recent stock splits.
Where is NetraMark headquartered?▼
NetraMark is headquartered in Toronto, Canada.